United Therapeutics Corp (UTHR)
264.27
-1.78
(-0.67%)
USD |
NASDAQ |
May 10, 16:00
264.32
+0.06
(+0.02%)
After-Hours: 20:00
United Therapeutics Price: 264.27 for May 10, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 10, 2024 | 266.00 | 269.81 | 263.93 | 264.27 | 391672.0 |
| May 09, 2024 | 263.87 | 266.38 | 260.41 | 266.05 | 474260.0 |
| May 08, 2024 | 266.38 | 268.21 | 260.66 | 261.09 | 581242.0 |
| May 07, 2024 | 261.41 | 266.65 | 260.93 | 266.22 | 686557.0 |
| May 06, 2024 | 263.63 | 264.85 | 256.08 | 260.51 | 587222.0 |
| May 03, 2024 | 260.33 | 262.51 | 255.93 | 262.40 | 779523.0 |
| May 02, 2024 | 255.10 | 260.34 | 253.93 | 258.13 | 717192.0 |
| May 01, 2024 | 243.00 | 258.48 | 236.65 | 255.14 | 1.411M |
| Apr 30, 2024 | 236.28 | 237.76 | 233.31 | 234.33 | 619524.0 |
| Apr 29, 2024 | 234.76 | 240.93 | 234.76 | 238.26 | 496599.0 |
| Apr 26, 2024 | 236.59 | 237.53 | 233.64 | 233.85 | 369691.0 |
| Apr 25, 2024 | 236.83 | 238.19 | 234.33 | 235.95 | 391825.0 |
| Apr 24, 2024 | 233.61 | 241.00 | 233.28 | 237.00 | 671048.0 |
| Apr 23, 2024 | 235.23 | 240.00 | 234.16 | 234.47 | 521396.0 |
| Apr 22, 2024 | 238.20 | 238.54 | 233.77 | 234.06 | 552493.0 |
| Apr 19, 2024 | 237.47 | 238.34 | 234.86 | 237.93 | 616033.0 |
| Apr 18, 2024 | 234.67 | 240.74 | 234.31 | 236.93 | 476359.0 |
| Apr 17, 2024 | 232.94 | 237.64 | 232.84 | 235.31 | 372437.0 |
| Apr 16, 2024 | 234.11 | 234.11 | 230.39 | 231.78 | 498304.0 |
| Apr 15, 2024 | 233.21 | 237.93 | 232.79 | 235.08 | 328014.0 |
| Apr 12, 2024 | 237.98 | 239.40 | 232.40 | 232.59 | 423587.0 |
| Apr 11, 2024 | 239.51 | 241.37 | 236.86 | 237.24 | 624222.0 |
| Apr 10, 2024 | 235.42 | 238.41 | 232.42 | 237.79 | 418971.0 |
| Apr 09, 2024 | 236.58 | 238.04 | 235.25 | 237.04 | 399157.0 |
| Apr 08, 2024 | 232.04 | 239.81 | 232.04 | 236.96 | 464422.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
74.85
Minimum
Jul 22 2019
280.43
Maximum
Dec 09 2022
177.17
Average
193.11
Median
Feb 23 2022
Price Benchmarks
| Liquidia Corp | 12.06 |
| Ligand Pharmaceuticals Inc | 87.28 |
| Esperion Therapeutics Inc | 2.19 |
| Vertex Pharmaceuticals Inc | 422.78 |
| Heron Therapeutics Inc | 2.77 |
Price Related Metrics
| PE Ratio | 12.50 |
| PS Ratio | 5.260 |
| PEG Ratio | 0.2945 |
| Price to Book Value | 2.196 |
| Price to Free Cash Flow | 17.47 |
| Earnings Yield | 8.00% |
| Market Cap | 11.72B |
| PEGY Ratio | 0.2945 |
| Operating PE Ratio | 10.46 |
| Normalized PE Ratio | 12.50 |